Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM; SULBACTAM SODIUM) | LOERadar

Viewing data from:

AMPICILLIN AND SULBACTAM

ANDA

AMPICILLIN SODIUM; SULBACTAM SODIUM | A065314 | ISTITUTO BIOCHIMICO ITALIANO SPA

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: UNASYN(TE code: AP)

Products (1)

#001 — EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL

AP

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Nov 27, 2006

No patent or exclusivity listings for this strength.